Comment from PubMed Commons 03 Jan 2017 RUBEN ABAGYAN | Nov 12 2015 14:44 ESTAdditional disclosure. One of the authors, R.A., has an equity interest in Molsoft, LLC. The terms of this arrangement have been reviewed and approved by the…